Deutsche Biotech Innovativ AG
F:DBI
Cash Flow Statement
Cash Flow Statement
Deutsche Biotech Innovativ AG
| Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | ||
|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||
| Net Income |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
(0)
|
(0)
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
0
|
0
|
0
|
0
|
(0)
|
|
| Cash from Operating Activities |
(0)
N/A
|
(0)
+22%
|
(0)
+29%
|
(0)
+30%
|
(0)
-695%
|
|
| Investing Cash Flow | ||||||
| Capital Expenditures |
(0)
|
0
|
0
|
(0)
|
(0)
|
|
| Other Items |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Cash from Investing Activities |
0
N/A
|
(0)
N/A
|
(0)
-3 233%
|
(0)
+3%
|
(0)
-218%
|
|
| Financing Cash Flow | ||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
1
|
|
| Other |
0
|
(0)
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
0
N/A
|
0
-2%
|
0
+2%
|
0
+2%
|
1
+341%
|
|
| Change in Cash | ||||||
| Net Change in Cash |
0
N/A
|
0
+650%
|
(0)
N/A
|
(0)
+97%
|
(0)
-8 500%
|
|
| Free Cash Flow | ||||||
| Free Cash Flow |
(0)
N/A
|
(0)
+23%
|
(0)
+29%
|
(0)
+27%
|
(0)
-681%
|
|